Published in Am J Gastroenterol on February 01, 1997
Current issues in endoscope reprocessing and infection control during gastrointestinal endoscopy. World J Gastroenterol (2006) 1.01
Serologic Evidence for Fecal-Oral Transmission of Helicobacter pylori. Am J Trop Med Hyg (2015) 0.80
The occupational risk of Helicobacter pylori infection among gastroenterologists and their assistants. BMC Infect Dis (2011) 0.78
Liver disease and Helicobacter. World J Gastroenterol (1999) 0.77
Seroprevalences of Helicobacter pylori and hepatitis A virus. Am J Gastroenterol (1998) 0.75
Helicobacter pylori transmission and hepatitis A. Am J Gastroenterol (1998) 0.75
Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science (1999) 24.31
Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion? Nat Med (1996) 5.09
Long-term survival in patients with hereditary hemochromatosis. Gastroenterology (1996) 4.00
Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med (1985) 3.73
Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet (2001) 3.62
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med (1995) 3.20
p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med (1998) 2.91
Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut (2006) 2.53
Macrolide-induced Churg-Strauss syndrome in a patient with atopy. Lancet (1997) 2.42
Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest (1997) 2.32
Diversity of Helicobacter pylori vacA and cagA genes and relationship to VacA and CagA protein expression, cytotoxin production, and associated diseases. J Clin Microbiol (1998) 2.26
TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma. Cell Death Differ (2005) 2.25
Perforation of the esophagus after dilation treatment for dysphagia in a patient with eosinophilic esophagitis. Endoscopy (2006) 2.24
Reduction in alkaline phosphatase is associated with longer survival in primary sclerosing cholangitis, independent of dominant stenosis. Aliment Pharmacol Ther (2014) 2.15
Putative reverse transcriptase intermediates of human hepatitis B virus in primary liver carcinomas. Science (1986) 2.00
Effects of a microbubble contrast agent on breast tumors: computer-assisted quantitative assessment with color Doppler US--early experience. Radiology (1998) 1.90
In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study. Ann Oncol (2005) 1.89
Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis. J Clin Invest (1998) 1.86
Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis. Gastroenterology (1996) 1.81
Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging (1999) 1.81
Is stenting necessary after balloon dilation of post-transplantation biliary strictures? Results of a prospective comparative study. Endoscopy (2008) 1.76
Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication. J Gen Virol (1993) 1.73
Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs. Cell Death Differ (2004) 1.62
Renal arteries: optimization of three-dimensional gadolinium-enhanced MR angiography with bolus-timing-independent fast multiphase acquisition in a single breath hold. Radiology (1999) 1.58
Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes. Proc Natl Acad Sci U S A (1985) 1.55
Phenprocoumon for prevention of shunt occlusion after transjugular intrahepatic portosystemic stent shunt: a randomized trial. Hepatology (1996) 1.53
Late diagnosis of Wilson's disease in a case without onset of symptoms. Acta Neurol Scand (1995) 1.52
Low vitamin E content in plasma of patients with alcoholic liver disease, hemochromatosis and Wilson's disease. J Hepatol (1994) 1.52
Hepatocellular uptake of oleate is energy dependent, sodium linked, and inhibited by an antibody to a hepatocyte plasma membrane fatty acid binding protein. Proc Natl Acad Sci U S A (1986) 1.50
Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates. Eur J Gastroenterol Hepatol (2001) 1.48
Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation (1997) 1.47
Manganese and chronic hepatic encephalopathy. Lancet (1995) 1.47
MR image texture analysis--an approach to tissue characterization. Magn Reson Imaging (1993) 1.43
Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Nat Med (1998) 1.42
Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS. Infect Immun (2001) 1.40
Endotheliotropic elephant herpes virus (EEHV) infection. The first PCR-confirmed fatal case in Asia. Vet Q (2006) 1.38
Precursor lesions of oesophageal cancer in young people in a high-risk population in China. Lancet (1989) 1.38
Establishment of persistent hepatitis C virus infection and replication in vitro. J Gen Virol (1997) 1.35
The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney. J Endocrinol (2005) 1.34
Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma. Dig Dis Sci (1997) 1.34
Tumor necrosis factor increases serum leptin levels in humans. J Clin Endocrinol Metab (1997) 1.32
Phosphatidylcholine and lysophosphatidylcholine in intestinal mucus of ulcerative colitis patients. A quantitative approach by nanoElectrospray-tandem mass spectrometry. Scand J Gastroenterol (2004) 1.29
Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. AJNR Am J Neuroradiol (2001) 1.29
In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease. Am J Pathol (1998) 1.28
High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results. J Clin Oncol (2001) 1.28
Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection. Clin Exp Immunol (1998) 1.27
Hepatocellular influx of [14C]oleate reflects membrane transport rather than intracellular metabolism or binding. Proc Natl Acad Sci U S A (1986) 1.26
Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. Hepatology (1990) 1.25
Mouse fatty acid transport protein 4 (FATP4): characterization of the gene and functional assessment as a very long chain acyl-CoA synthetase. Gene (2001) 1.24
Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation? Diabetologia (1984) 1.23
Analysis of hepatitis C virus core protein interaction domains. J Gen Virol (1997) 1.21
Role of plasma membrane ligand-binding proteins in the hepatocellular uptake of albumin-bound organic anions. Hepatology (1987) 1.21
Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. Arterioscler Thromb Vasc Biol (1997) 1.21
Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding. Gastroenterology (1997) 1.20
MR tissue characterization of intracranial tumors by means of texture analysis. Magn Reson Imaging (1993) 1.20
Differences in the regulation of iron regulatory protein-1 (IRP-1) by extra- and intracellular oxidative stress. J Biol Chem (1997) 1.19
Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. J Biol Chem (1997) 1.17
Release of thrombomodulin from endothelial cells by concerted action of TNF-alpha and neutrophils: in vivo and in vitro studies. Immunology (1996) 1.17
Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. Clin Cancer Res (1998) 1.17
Identification, isolation, and partial characterization of a fatty acid binding protein from rat jejunal microvillous membranes. J Clin Invest (1985) 1.16
Direct determination of Helicobacter pylori vacA genotypes and cagA gene in gastric biopsies and relationship to gastrointestinal diseases. Am J Gastroenterol (1999) 1.16
Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival. Cancer Res (1998) 1.14
Copper in disorders with neurological symptoms: Alzheimer's, Menkes, and Wilson diseases. Brain Res Bull (2001) 1.14
Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution. Eur Radiol (2002) 1.13
Proliferation cell nuclear antigen (clone 19A2) correlates with 5-bromo-2-deoxyuridine labelling in human colonic epithelium. Gut (1993) 1.12
Characterization of large surface proteins of hepatitis B virus by antibodies to preS-S encoded amino acids. Virology (1986) 1.12
Interleukin-6 expression and regulation in rat enteric glial cells. Am J Physiol Gastrointest Liver Physiol (2001) 1.10
Physicochemical and immunohistological studies of a sulfobromophthalein- and bilirubin-binding protein from rat liver plasma membranes. J Clin Invest (1983) 1.10
Direct evidence for catalase as the predominant H2O2 -removing enzyme in human erythrocytes. Blood (1997) 1.08
Usual interstitial pneumonia. Quantitative assessment of high-resolution computed tomography findings by computer-assisted texture-based image analysis. Invest Radiol (1997) 1.07
Protein-mediated facilitated uptake processes for fatty acids, bilirubin, and other amphipathic compounds. Proc Soc Exp Biol Med (1996) 1.07
Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe (-/-) mice. Diabetologia (2012) 1.07
False-positive anti-HCV tests in rheumatoid arthritis. Lancet (1990) 1.06
Detection of pre-S1 proteins in serum and liver of HBsAg-positive patients: a new marker for hepatitis B virus infection. Hepatology (1986) 1.06
Pre-S1 antigens and antibodies early in the course of acute hepatitis B virus infection. J Virol (1986) 1.06
Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy. Eur Radiol (2002) 1.06
Fast fluid-attenuated inversion-recovery (FLAIR) MRI in the assessment of intraaxial brain tumors. J Magn Reson Imaging (1998) 1.05
Synthesis of the X-protein of hepatitis B virus in vitro and detection of anti-X antibodies in human sera. Virology (1987) 1.05
Progressive sclerosing cholangitis after septic shock: a new variant of vanishing bile duct disorders. Gut (2003) 1.05
[Integrated skills laboratory concept for undergraduate training in internal medicine]. Dtsch Med Wochenschr (2005) 1.05
Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. Cancer Res (1997) 1.04
Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes. J Hepatol (1998) 1.04
Effective infection, apoptotic cell killing and gene transfer of human hepatoma cells but not primary hepatocytes by parvovirus H1 and derived vectors. Cancer Gene Ther (2001) 1.04
Diagnostic accuracy of computerized B-scan texture analysis and conventional ultrasonography in diffuse parenchymal and malignant liver disease. J Clin Ultrasound (1985) 1.04
Altered bile acid metabolism in primary biliary cirrhosis. Dig Dis Sci (1981) 1.03
Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis. Hepatology (1990) 1.02
Effects of DPP-4 inhibition on cardiac metabolism and function in mice. J Mol Cell Cardiol (2011) 1.02
Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study. J Hepatol (1997) 1.02
Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus. Hepatology (1996) 1.01
Studies of albumin binding to rat liver plasma membranes. Implications for the albumin receptor hypothesis. Biochim Biophys Acta (1983) 1.01